Symbiosis boosts US presence in response to market growth

UK-based sterile filling specialist Symbiosis Pharmaceutical Services has strengthened its North American footprint with the appointment of a US-based business development manager to support increased demand from biotech companies for its manufacturing services.The move to reinforce Symbiosis’ presence in North America is bolstered by the recent surge in funding of biotech firms in the US. A more positive investor climate in the US continues to… Read More

Au revoir CPhI Paris

From the 7th until the 10th October the Symbiosis team attended CPhI, one of Europe’s largest pharmaceutical conferences held in Paris, France. Our two European Business Development Managers and our CEO were in attendance at the event with support from our friends at Scottish Development International. Thanks to those of you who visited our stand, especially given the challenges of navigating the… Read More

Symbiosis to attend CPhI

Symbiosis will be returning for the third consecutive year to exhibit at the CPhI conference to promote our world class sterile manufacturing capabilities with support from our friends from Scottish Development International. The event held at Nord Villepinte, Paris, France, from the 7th to 9th October is one of the world’s leading pharmaceutical events. It provides an exciting opportunity for Symbiosis to… Read More

Symbiosis to attend Biotech Outsourcing Strategies cmc

Symbiosis, a leading cGMP manufacturer of sterile pharmaceuticals for clinical trials, is looking forward to attending a key event in the drug development outsourcing calendar later this month.  We will be attending Biotech Outsourcing Strategies (BOS) cmc on the 12th June in Copenhagen, Denmark.With a programme including small molecule and biologics tracks and a strong emphasis on virtual drug development, BOS cmc has… Read More

Pharmaceutical Breakthrough

Pharmaceutical and biotech companies have made huge advances recently in the fight against cancer. The Daily Mail has published a heart-warming article highlighting the huge effect that a new class of drugs called Antibody Drug Conjugates (ADCs) drugs can have on people. http://www.dailymail.co.uk/health/article-2567455/Cancer-patients-lethal-70-tumours-disappear-just-two-WEEKS-thanks-pioneering-treatment.htmlA British man suffering from a rare form of lymphoma was given only weeks to live after scans showed that… Read More

Symbiosis gains Approval for French Tax Credit

Recently Symbiosis Pharmaceutical Services applied for a CIR (Crédit d’Impôt de Recherche) tax accreditation from the Minister of higher Education and research in France for R&D work on behalf of French companies. Our request was favourably accepted and we are now approved until 2016.The CIR tax accreditation has provided Symbiosis with a strong basis to working with French companies and allows eligible… Read More

Symbiosis reçoit l’agrément pour le CIR

Symbiosis Pharmaceutical Services a fait récemment une demande pour un agrément CIR – Crédit d’Impôt Recherche – auprès du Ministère de l’Enseignement Supérieur et de la Recherche en tant que prestataire pour des travaux R&D. Notre demande a été accueillie favorablement et est accordée au titre des années 2014, 2015, 2016.L’agrément CIR nous donne l’opportunité de travailler avec les entreprises françaises et… Read More

UNICEF Campaign – Massive Success

Last week we sent out a newsletter inviting you all to connect with us via LinkedIn and Twitter and in return we would donate ten Tetanus vaccines per follower to UNICEF. We had many reasons behind this, including : raising our social media profile, we put out a lot of interesting content via our social media networks on a weekly basis and… Read More

Get In Touch